explore -WSS

explore

author：hotspot 2025-10-01 23:04:46 - browse：1

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Lasker Awards 2023: Winners in biomedical research

WSS

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Second xenotransplant done with gene

Readout LOUD podcast: possible new ALS drug, artificial wombs

How Vertex's cystic fibrosis drug is changing patients' lives

Readout LOUD podcast: possible new ALS drug, artificial wombs

The battle over 'scope creep' and who gets to be called 'doctor'

leisure time

explore

entertainment

Jerome Adams on the need for new antivirals for Covid

Rise in cancer among younger people worries and puzzles doctors

Novavax promises a turnaround & Lilly roils the obesity market

Changes to biosimilar regulatory framework must prioritize patients

In age of alternative facts, a scholarly course on calling out crap

Lasker Awards 2023: Winners in biomedical research

The high cost of giving birth even with insurance

FDA panel to weigh approval of NurOwn, controversial ALS drug

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Wikipedia

Intarcia’s device

Search called off for baby washed away in Pennsylvania flash flood

Truvian presents data for its desktop blood

UHS says company favors patients whose insurance pays more

Emergency workers more likely to restrain Black patients: study

Biotech stock slump in 2023: awaiting the turnaround

explore

Wikipedia

hotspot

Wikipedia